Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Unknown 5Recruiting 5Completed 4Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3UNKNOWN 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 3Thoracic 2Dermatologic 1Breast 1

Conditions

Esophageal Neoplasms 3Esophageal Squamous Cell Carcinoma 2Pathologic Complete Response 1Lymphatic Metastasis 1Carcinoma, Squamous Cell 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × TP protocol × Gastrointestinal × Clear all
NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Unknown
44 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

NCT03927495 2019-05-29

KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Shanghai Chest Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

NCT02461043 2015-09-01

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 3 Unknown
386 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01444547 2014-05-06

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

ChineseAMS

Phase 2 Unknown
92 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡